In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry.
Newitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, Covidien. The spinout of the spinal and dental businesses into a NewCo will allows the company to focus more resources on selling knee and hip implants as well as building out an impressive robotics franchise and a potentially sector-leading line of digital tools and sensors.
“Zimmer has effectively gone from a share loser for almost a decade leading up to when Bryan Hanson took over to a share-taking position,” he said in an interview with Chris Newmarker, executive editor of life sciences. “This most recent quarter, their share gains have widened quite dramatically.”
In our second interview, Greg Lucier, executive chairman of Corza Medical, says the company will used an advanced digitization process it acquired from Surgical Specialties to compete with the “almost monopolistic” leaders like Medtronic and Johnson & Johnson’s Ethicon. Corza Medical is backed by private equity giant GTCR and led by Lucier, who previously served as CEO of Life Technologies, a diagnostics supply business that was acquired by Thermo Fisher Scientific for $13.6 billion.
Zimmer Biomet and Corza Medical led this week’s Newmarkers Newsmakers, but we also hear news about Philips, CooperSurgical, Aegea, 3M, Abbott as well of mentions of Medtronic, Boston Scientific and others.
Subscribe now on your favorite podcast player!